The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Evolus Inc (NASDAQ: EOLS) closed at $9.30 down -5.20% from its previous closing price of $9.81. In other words, the price has decreased by -$5.20 from its previous closing price. On the day, 2.38 million shares were traded.
Ratios:
For a deeper understanding of Evolus Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 17, 2025, initiated with a Buy rating and assigned the stock a target price of $21.
On January 29, 2024, Barclays Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $10 to $16.
On June 23, 2022, Needham started tracking the stock assigning a Buy rating and target price of $18.Needham initiated its Buy rating on June 23, 2022, with a $18 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 12 ’25 when Avelar Rui sold 3,385 shares for $9.87 per share. The transaction valued at 33,397 led to the insider holds 359,082 shares of the business.
Beaver Sandra sold 6,494 shares of EOLS for $65,070 on May 13 ’25. The Chief Financial Officer now owns 167,089 shares after completing the transaction at $10.02 per share. On May 12 ’25, another insider, MOATAZEDI DAVID, who serves as the insider of the company, sold 15,787 shares for $9.87 each. As a result, the insider received 155,756 and left with 492,832 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.18.
Stock Price History:
Over the past 52 weeks, EOLS has reached a high of $17.82, while it has fallen to a 52-week low of $8.67. The 50-Day Moving Average of the stock is -15.47%, while the 200-Day Moving Average is calculated to be -30.16%.
Shares Statistics:
A total of 64.45M shares are outstanding, with a floating share count of 56.92M. Insiders hold about 11.72% of the company’s shares, while institutions hold 84.45% stake in the company.
Earnings Estimates
The stock of Evolus Inc (EOLS) is currently being evaluated by 3.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.06, with high estimates of $0.01 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.01 and -$0.22 for the fiscal current year, implying an average EPS of -$0.13. EPS for the following year is $0.58, with 4.0 analysts recommending between $0.94 and $0.39.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $82.18M this quarter.It ranges from a high estimate of $86.38M to a low estimate of $80M. As of the current estimate, Evolus Inc’s year-ago sales were $66.91MFor the next quarter, 7 analysts are estimating revenue of $85.31M. There is a high estimate of $91.18M for the next quarter, whereas the lowest estimate is $82.32M.
A total of 7 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $353.73M, while the lowest revenue estimate was $345.1M, resulting in an average revenue estimate of $348.21M. In the same quarter a year ago, actual revenue was $266.27MBased on 7 analysts’ estimates, the company’s revenue will be $463.84M in the next fiscal year. The high estimate is $485M and the low estimate is $444.3M.
